An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Incyte Corporation
BerGenBio ASA
Stanford University
Pfizer
Incyte Corporation
Memorial Sloan Kettering Cancer Center